Holen Sie sich die Stockscreener-App
2.0501
8.48%
-0.1899
Cerus Corp Aktie (CERS) Neueste Nachrichten
CERS Earnings History & Surprises | EPS & Revenue Results | CERUS CORP (NASDAQ:CERS) - ChartMill
Cerus Corporation (NASDAQ:CERS) Q4 2025 Earnings Call Transcript - Insider Monkey
Cerus (CERS) Revenue Growth Outpaces Market And Reinforces Bullish Margin Recovery Narrative - simplywall.st
Cerus at TD Cowen Conference: Strategic Growth in Blood Transfusion - Investing.com South Africa
$CERS stock is down 16% today. Here's what we see in our data. - Quiver Quantitative
MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Cerus Corp (CERS) Q4 2025 Earnings Call Highlights: Record Reven - GuruFocus
Cerus: Q4 Earnings Snapshot - theheraldreview.com
Cerus Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Cerus Q4 Earnings Call Highlights - Yahoo Finance
Cerus Corp (NASDAQ:CERS) Reports Mixed Q4 2025 Results, Stock Falls on Revenue Miss - ChartMill
Cerus: Q4 Financial Results Overview - Bitget
Earnings call transcript: Cerus Corporation Q4 2025 exceeds revenue expectations - Investing.com
Cerus (NASDAQ:CERS) Posts Quarterly Earnings Results, Hits Expectations - MarketBeat
Cerus 10-K: Revenue $233.8M, product growth drives results - TradingView
Cerus (NASDAQ: CERS) outlines INTERCEPT blood system pipeline - Stock Titan
CERS Forecasts Growth in 2026 Product Revenue - GuruFocus
Cerus Corporation (CERS) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
Cerus falls 7% after posting in-line Q4 earnings, revenue beat - Investing.com Canada
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Cerus Q4 Earnings Assessment - Benzinga
Cerus (Nasdaq: CERS) grows 2025 revenue 16% and reaffirms 2026 outlook - Stock Titan
CERSCerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results - ADVFN Ltd
Cerus (CERS) Set to Release Q4 Earnings with Modest Revenue Grow - GuruFocus
CERS PE Ratio & Valuation, Is CERS Overvalued - Intellectia AI
Cerus (NASDAQ:CERS) Stock Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Earnings Preview For Cerus - Sahm
Live Cerus fireside chat set for TD Cowen health conference March 3 - Stock Titan
Cerus (NASDAQ:CERS) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
Cerus sets March 2 date for Q4 and full-year 2025 earnings call - Stock Titan
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026 - Yahoo Finance
Cerus (CERS) Projected to Post Quarterly Earnings on Thursday - Defense World
Will Cerus Corporation (CU2) stock announce special dividend2025 Key Lessons & Proven Capital Preservation Tips - mfd.ru
Market Wrap: Is VLGEAs ROE strong enoughQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Cerus (CERS) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Cerus (NASDAQ:CERS) Stock Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Cerus (NASDAQ:CERS) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Cerus announces planned board transition as director departs - The Globe and Mail
Cerus director Timothy L. Moore to step down after 2026 annual meeting - Investing.com
New German trial tests safer platelets for cancer patients - stocktitan.net
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Lowers Stock Holdings in Cerus Corporation $CERS - MarketBeat
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Cerus (NASDAQ:CERS) Sets New 52-Week HighWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Cerus (CERS) and Kura Oncology (KURA) - The Globe and Mail
TD Cowen reiterates Buy rating on Cerus stock after strong Q4 results - Investing.com
CERS Projects Revenue Growth in 2026 - GuruFocus
Cerus (CERS) Reports Significant Global Expansion of INTERCEPT B - GuruFocus
Cerus (CERS) Reports Strong Revenue Growth Driven by INTERCEPT F - GuruFocus
Cerus expects 14% jump in 2025 topline, guides 2026 (CERS:NASDAQ) - Seeking Alpha
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook - Yahoo Finance
Revenue Check: Why Cerus Corporation stock is recommended by analysts2025 Volume Leaders & Risk Controlled Daily Trade Plans - Улправда
Cerus (NASDAQ:CERS) Shares Pass Above 200-Day Moving Average – Should You Sell? - Defense World
2026 world cup canada semifinals top scorers low block match prediction analysisMarket Risk Summary & AI Driven Price Forecasts - ulpravda.ru
What hedge fund activity signals for CNVS stockWeekly Gains Report & Safe Entry Zone Identification - ulpravda.ru
What insider trading reveals about Cerus Corporation stockMarket Volume Report & Verified Chart Pattern Trade Signals - Улправда
2026 world cup team news tips: Why Cerus Corporation stock is recommended by analysts2026 world cup usa national team quarterfinals young talents set piece tactics knockout prediction guide - ulpravda.ru
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
TD Cowen Sees Compelling Long-Term Value in Cerus Corporation (CERS) - Finviz
2.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):